Your Article Summary
See Latest ArticlesAddition of 2.5g l-arginine in a fatty meal prevents the lipemia-induced endothelial dysfunction in healthy volunteers
Atherosclerosis, 06/26/09
Borucki K et al. - 2.5g l-arginine, but not phenyalanine or leucine, is able to prevent the lipemic dysfunction of the endothelium.
Today in Atherosclerosis/Lipids...keeping you current
Receive free subspecialty "5-minute updates" via email
Quantification of noncalcified coronary atherosclerotic plaques with Dual Source Computed Tomography: comparison to intravascular ultrasound
Heart, 11/30/09
What is the clinical usefulness of the metabolic syndrome? The Casale Monferrato study
Journal of Hypertension, 11/30/09
Low-Density Lipoprotein Cholesterol Reduction and Goal Achievement With Ezetimibe/Simvastatin Versus Atorvastatin or Rosuvastatin in Patients With Diabetes, Metabolic Syndrome, or Neither Disease, Stratified By National Cholesterol Education Program Risk Category
Metabolic Syndrome and Related Disorders, 11/30/09
Today in Prevention...keeping you current
Receive free subspecialty "5-minute updates" via email
The JUPITER and AURORA clinical trials for rosuvastatin in special primary prevention populations: perspectives, outcomes, and consequences
Vascular Health and Risk Management, 11/30/09
Low-Density Lipoprotein Cholesterol Reduction and Goal Achievement With Ezetimibe/Simvastatin Versus Atorvastatin or Rosuvastatin in Patients With Diabetes, Metabolic Syndrome, or Neither Disease, Stratified By National Cholesterol Education Program Risk Category
Metabolic Syndrome and Related Disorders, 11/30/09
Inflammation markers and metabolic characteristics of subjects with one-hour plasma glucose levels
Diabetes Care, 11/23/09